NCT04496635

Brief Summary

The Nosocomial Infection Surveillance Program in Catalonia (VINCat) monitors surgical site infection (SSI) in elective colorectal surgery since 2007 in 55 public and private acute care hospitals. These hospitals perform active and prospective standardized surveillance of elective colorectal resections. Post-discharge surveillance is mandatory at least up to 30 days after surgery. Hospitals are classified according to their size into three groups: \>500 hospital beds; 200-500 beds; \<200 beds. Aim. To examine the effect on SSI rate of a specific preventative bundle in elective colorectal surgery. Methods. Pragmatic study using VINCat prospective colorectal database from 2007 to 2018. In 2016, a bundle of six preventative measures was recommended to the VINCat hospitals. To compare the results of SSI before (baseline phase, BP) and after the bundle implementation (implementation phase, IP) a logistic regression model has been established. The results will be shown as Odds Ratio (OR) and the corresponding confidence intervalsCI95. The significance level will be fixed at 5% (P \< 0.05).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
13.5 years until next milestone

First Submitted

Initial submission to the registry

July 14, 2020

Completed
20 days until next milestone

First Posted

Study publicly available on registry

August 3, 2020

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

August 22, 2023

Status Verified

August 1, 2023

Enrollment Period

18.9 years

First QC Date

July 14, 2020

Last Update Submit

August 21, 2023

Conditions

Keywords

SurveillancePreventative measuresBundle of careColorectal surgerySurgical site infectionPrevention

Outcome Measures

Primary Outcomes (1)

  • Surgical site infection rate

    Overall surgical infection rate

    30 days

Secondary Outcomes (3)

  • Organ/space surgical infection rate

    30 days

  • Hospital type-Surgical infection rate

    30 days

  • Analysis (logistic regression model) of the efficacy of each preventive measure

    30 days

Study Arms (2)

Baseline phase

NO INTERVENTION

Patients included in the VINCat program, and operated on colorectal surgery between 2007 and 2015 in Catalonia

Implementation phase

EXPERIMENTAL

Patients included in the VINCat program, and operated on colorectal surgery between 2016 and 2018 in Catalonia

Other: Implementation of a bundle of care

Interventions

Implementation phase

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Colon or rectal elective surgery.

You may not qualify if:

  • Peritonitis at the time of intervention ("dirty" surgery) Patients who underwent multiple procedures during the same surgery, for example resection of liver metastases Centers that performed less tan 10 surgical procedures annually Centers that have not been able to ensure prospective surveillance during hospitalization or effective monitoring of cases within 30 days of the intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital General de Granollers

Granollers, Barcelona, 08402, Spain

RECRUITING

MeSH Terms

Conditions

Colonic NeoplasmsSurgical Wound Infection

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesWound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Josep M Badia-Perez, MD, PhD

    Fundació Hospital General de Granollers

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gemma Molist, MD, PHD

CONTACT

Josep M Badia, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SEQUENTIAL
Model Details: The study compare two phases: baseline (BP), from 2008 to 2015, and implementation (IP), from 2016 to 2018.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 14, 2020

First Posted

August 3, 2020

Study Start

January 1, 2007

Primary Completion

November 30, 2025

Study Completion

December 30, 2025

Last Updated

August 22, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Data will be shared when requested

Locations